Catalyst Wire Dossier Catalyst Wire Dossier

Zioxtenzo

pegfilgrastim · Sandoz GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zioxtenzo, covering 2017-04-25 to 2017-04-25. Get the full timeline:

Most recent: EMA Application withdrawn: Zioxtenzo (pegfilgrastim) — Sandoz GmbH

See pricing